drugset / Trial / NCT00915135
Efficacy and Safety of Ramelteon on Chronic Insomnia
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this study is to determine the dose response of Ramelteon, once daily (QD), in Japanese subjects with Chronic Insomnia
Timeline
- Start
- 2002-05
- Primary completion
- 2003-12
- Completion
- 2003-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ramelteon | Unknown | 4 mg | Oral |
| Subject | Ramelteon | Unknown | 8 mg | Oral |
| Subject | Ramelteon | Unknown | 16 mg | Oral |
| Subject | Ramelteon | Unknown | 32 mg | Oral |